Wikidata entity: Q66042172
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 300 |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q16 (Canada) | Canada |
| P17 | country | ... | Q28 (Hungary) | Hungary |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q31 (Belgium) | Belgium |
| P17 | country | ... | Q36 (Poland) | Poland |
| P17 | country | ... | Q183 (Germany) | Germany |
| P582 | end time | ... | 2019-12-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q1426443 (nocturia) | nocturia |
| P6153 | research site | ... | Q833670 (Katholieke Universiteit Leuven) | Katholieke Universiteit Leuven |
| P6153 | research site | ... | Q1920549 (Ghent University Hospital) | Ghent University Hospital |
| P6153 | research site | ... | Q2936440 (Antwerp University Hospital) | Antwerp University Hospital |
| P6153 | research site | ... | Q30269506 (Bay State Clinical Trials) | Bay State Clinical Trials |
| P6153 | research site | ... | Q30269546 (Avail Clinical Research) | Avail Clinical Research |
| P6153 | research site | ... | Q30269721 (Clinical Research of South Florida) | Clinical Research of South Florida |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270199 (Peters Medical Research) | Peters Medical Research |
| P6153 | research site | ... | Q30270502 (South Florida Medical Research) | South Florida Medical Research |
| P1813 | short name | Monolingualtext | DAWN | ??? |
| P580 | start time | ... | 2017-07-27 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults | ??? |
| P3098 | ClinicalTrials.gov ID | NCT03201419 |
Why not click here or view trends?
log id: 4823226